Election of Directors
The four candidates nominated for election to the Company’s Board of Directors (the “Board”) and listed in the Company’s management information and proxy circular dated
Votes For | % For | Votes Withheld | % Withheld | |
17,767,804 | 77.74% | 5,088,933 | 22.26% | |
17,425,384 | 76.24% | 5,431,353 | 23.76% | |
20,217,074 | 88.45% | 2,639,663 | 11.55% | |
20,239,145 | 88.55% | 2,617,592 | 11.45% | |
Appointment of Auditors
The Company’s shareholders have approved the re-appointment of
Approval of the 2024 Equity Incentive Plan
The Company’s shareholders have approved the 2024 Equity Incentive Plan of the Company (the “Incentive Plan”), pursuant to which the Company is able to issue share-based long-term incentives. All directors, officers, employees and service providers of the Company and/or its affiliates are eligible to receive awards under the Incentive Plan, subject to the terms of the Incentive Plan. Awards include common share purchase options, stock appreciation rights, restricted share awards, restricted share bonuses, restricted share units, performance shares, performance units, cash-based awards, and other share-based awards under the Incentive Plan. A copy of the Incentive Plan is attached as Schedule “A” to the Circular. As a result of the adoption of the Incentive Plan, no future awards or grants will be made under the Company’s current equity incentive plan, which became effective on
A report of voting results describing each of the matters voted upon at the Meeting has been filed on SEDAR+ under the Company’s issuer profile at www.sedarplus.ca.
ABOUT QUIPT HOME MEDICAL CORP.
The Company provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in
For further information please visit our website at www.quipthomemedical.com, or contact:
VP of Corporate Development
859-300-6455
cole.stevens@myquipt.com
Chief Executive Officer
859-300-6455
investorinfo@myquipt.com
Source:
2024 GlobeNewswire, Inc., source